• 1
    Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF: The development of disability in rheumatoid arthritis. Arthritis Rheum 29: 494500, 1986
  • 2
    Pincus T, Callahan LF: Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis. Scand J Rheumatol Suppl 79: 6796, 1989
  • 3
    Pincus T: Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 41: 10371041, 1988
  • 4
    Kushner I: Does aggressive therapy of rheumatoid arthritis affect outcome? J Rheumatol 16: 14, 1989
  • 5
    Harris ED Jr: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322: 12771289, 1990
  • 6
    Fries JF: Reevaluating the therapeutic approach to rheumatoid arthritis: the “sawtooth” strategy. J Rheumatol Suppl 17: 1215, 1990
  • 7
    Kushner I, Dawson NV: Changing perspectives in the treatment of rheumatoid arthritis. J Rheumatol 19: 18311834, 1992
  • 8
    Weinblatt ME, Maier AL: The duration of rheumatoid arthritis does not predict response to treatment (abstract). Arthritis Rheum 35 (suppl 9): S203, 1992
  • 9
    Borg G, Allander E, Lund B, Berg E, Brodin U, Pettersson H, Trang L: Auranofin improves outcome in early rheumatoid arthritis: results from a 2-year, double-blind placebo controlled study. J Rheumatol 15: 17471754, 1988
  • 10
    Strand V, Lee ML, and the CD 5 Plus Investigators Group: Differential patterns of response in patients with rheumatoid arthritis following administration of an anti-CD 5 immunocon-jugate. Clin Exp Rheumatol 11 (suppl 8): S161–S163, 1993
  • 11
    Felson D, Chernoff M, Wang M, Anderson J: Does duration of disease affect patient response to second-line drugs in rheumatoid arthritis? (abstract). Arthritis Rheum 36 (suppl 9): S178, 1993
  • 12
    Harris ED Jr: Clinical features of rheumatoid arthritis, Textbook of Rheumatology. Fourth edition. Edited by WNKelly, EDHarrisJr SRuddy, CBSledge. Philadelphia, WB Saunders, 1993
  • 13
    Linos A, Worthington JW, O'Fallon WM, Kurland LT: The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 111: 8798, 1980
  • 14
    Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 1958
  • 15
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 16
    Cox DR, Oakes D: Analysis of Survival Data. London, Chapman and Hall, 1984
  • 17
    SAS Institute, Inc: SAS/STAT PHREG preliminary documentation. Cary, North Carolina, SAS Institute, Inc., 1991
  • 18
    Chan K-WA, Felson DT, Yood RA, Walker AM: Incidence of rheumatoid arthritis in Central Massachusetts. Arthritis Rheum 36: 16911696, 1993
  • 19
    Mechanic D: The epidemiology of illness behavior and its relationship to physical and psychological distress, Symptoms, Illness Behavior, and Help-seeking. Edited by DMechanic. New York, Prodist, 1982
  • 20
    Cronan TA, Kaplan RM, Posner L, Blumberg E, Kozin F: Prevalence of the use of unconventional remedies for arthritis in a metropolitan community. Arthritis Rheum 32: 16041607, 1989